Loading...
Cyclophosphamide
India Pharmaceutical Trade Intelligence
Who Supplies Cyclophosphamide to India from UNITED STATES
India's cyclophosphamide imports from UNITED STATES total $592.7K across 42 shipments from 11 foreign suppliers. Asaman Inc leads with $173.3K in import value; the top 5 suppliers together control 86.4% of this origin. Leading Indian buyers include MYLAN LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for cyclophosphamide — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
Asaman Inc is the leading Cyclophosphamide supplier from UNITED STATES to India, with import value of $173.3K across 3 shipments. The top 5 suppliers — Asaman Inc, M/S ESPEE BIOPHARMA & FINECHEM LLC, Pharmaceutical Buyers Inc, AMSTERDAM PHARMA (APTEKA RX INC), Pharmaceutical Buyers, Inc. — collectively account for 86.4% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | Asaman Inc | $173.3K | 3 | 29.2% |
| 2 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $156.2K | 9 | 26.3% |
| 3 | Pharmaceutical Buyers Inc | $84.9K | 3 | 14.3% |
| 4 | AMSTERDAM PHARMA (APTEKA RX INC) | $54.9K | 5 | 9.3% |
| 5 | Pharmaceutical Buyers, Inc. | $42.8K | 1 | 7.2% |
| 6 | AGRACE PHARMA | $21.0K | 4 | 3.5% |
| 7 | ESPEE BIOPHARMA & FINECHEM LLC | $18.2K | 3 | 3.1% |
| 8 | AGRACE PHARMA. | $15.1K | 3 | 2.5% |
| 9 | AGRACE PHARMA, | $13.2K | 3 | 2.2% |
| 10 | SPRING BIO SOLUTION, | $12.7K | 3 | 2.1% |
| 11 | NAVINTA LLC | $232 | 5 | 0.0% |
Showing top 11 of 11 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $301.1K | 7 | 50.8% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $156.2K | 9 | 26.3% |
| 3 | EXTROVIS PRIVATE LIMITED | $58.3K | 6 | 9.8% |
| 4 | DR.REDDY'S LABORATORIES LTD | $33.3K | 6 | 5.6% |
| 5 | GLENMARK PHARMACEUTICALS LIMITED | $26.0K | 6 | 4.4% |
| 6 | HETERO LABS LIMITED | $12.6K | 2 | 2.1% |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $5.0K | 1 | 0.8% |
| 8 | APOTHECON PHARMACEUTICALS PVT LTD | $232 | 5 | 0.0% |
Import Statistics
- Import Value
- $592.7K
- Shipments
- 42
- Foreign Suppliers
- 11
- Indian Buyers
- 8
- Avg. Shipment
- $14.1K
Other Cyclophosphamide Import Origins
Related Analysis
Frequently Asked Questions — Cyclophosphamide Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Cyclophosphamide suppliers from UNITED STATES to India?
The top Cyclophosphamide suppliers from UNITED STATES to India include Asaman Inc, M/S ESPEE BIOPHARMA & FINECHEM LLC, Pharmaceutical Buyers Inc. The leading supplier is Asaman Inc with import value of $173.3K USD across 3 shipments. India imported Cyclophosphamide worth $592.7K USD from UNITED STATES in total across 42 shipments.
QHow much Cyclophosphamide does India import from UNITED STATES?
India imported Cyclophosphamide worth $592.7K USD from UNITED STATES across 42 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Cyclophosphamide from UNITED STATES?
The main Indian buyers of Cyclophosphamide sourced from UNITED STATES include MYLAN LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, EXTROVIS PRIVATE LIMITED. The largest buyer is MYLAN LABORATORIES LIMITED with $301.1K in imports across 7 shipments.
QWhat is the total value of Cyclophosphamide imports from UNITED STATES to India?
The total value of Cyclophosphamide imports from UNITED STATES to India is $592.7K USD, across 42 shipments and 11 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Cyclophosphamide.
- 2.Supplier/Buyer Matching: 11 foreign suppliers from UNITED STATES and 8 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $592.7K aggregated from 42 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
42 Verified Shipments
11 suppliers, 8 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists